Logo image of CROX

CROCS INC (CROX) Stock Fundamental Analysis

NASDAQ:CROX - Nasdaq - US2270461096 - Common Stock - Currency: USD

107.6  -1.28 (-1.18%)

After market: 107.58 -0.02 (-0.02%)

Fundamental Rating

7

Taking everything into account, CROX scores 7 out of 10 in our fundamental rating. CROX was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX gets an excellent profitability rating and is at the same time showing great financial health properties. A decent growth rate in combination with a cheap valuation! Better keep an eye on CROX. With these ratings, CROX could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year CROX was profitable.
CROX had a positive operating cash flow in the past year.
In the past 5 years CROX has always been profitable.
In the past 5 years CROX always reported a positive cash flow from operatings.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

CROX has a Return On Assets of 19.74%. This is amongst the best in the industry. CROX outperforms 93.88% of its industry peers.
CROX has a better Return On Equity (51.75%) than 95.92% of its industry peers.
Looking at the Return On Invested Capital, with a value of 23.23%, CROX belongs to the top of the industry, outperforming 91.84% of the companies in the same industry.
CROX had an Average Return On Invested Capital over the past 3 years of 22.59%. This is significantly above the industry average of 11.76%.
The 3 year average ROIC (22.59%) for CROX is below the current ROIC(23.23%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 19.74%
ROE 51.75%
ROIC 23.23%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

CROX's Profit Margin of 23.16% is amongst the best of the industry. CROX outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of CROX has grown nicely.
CROX's Operating Margin of 25.50% is amongst the best of the industry. CROX outperforms 100.00% of its industry peers.
CROX's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 58.76%, CROX is doing good in the industry, outperforming 71.43% of the companies in the same industry.
In the last couple of years the Gross Margin of CROX has grown nicely.
Industry RankSector Rank
OM 25.5%
PM (TTM) 23.16%
GM 58.76%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CROX is creating value.
The number of shares outstanding for CROX has been reduced compared to 1 year ago.
Compared to 5 years ago, CROX has less shares outstanding
The debt/assets ratio for CROX has been reduced compared to a year ago.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CROX has an Altman-Z score of 3.92. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.92, CROX is doing good in the industry, outperforming 77.55% of the companies in the same industry.
CROX has a debt to FCF ratio of 1.46. This is a very positive value and a sign of high solvency as it would only need 1.46 years to pay back of all of its debts.
The Debt to FCF ratio of CROX (1.46) is better than 79.59% of its industry peers.
CROX has a Debt/Equity ratio of 0.74. This is a neutral value indicating CROX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.74, CROX is doing worse than 69.39% of the companies in the same industry.
Even though the debt/equity ratio score it not favorable for CROX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 1.46
Altman-Z 3.92
ROIC/WACC2.28
WACC10.18%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

A Current Ratio of 1.18 indicates that CROX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.18, CROX is not doing good in the industry: 91.84% of the companies in the same industry are doing better.
A Quick Ratio of 0.70 indicates that CROX may have some problems paying its short term obligations.
CROX has a Quick ratio of 0.70. This is amonst the worse of the industry: CROX underperforms 87.76% of its industry peers.
The current and quick ratio evaluation for CROX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.7
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

CROX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.31%, which is quite good.
Measured over the past years, CROX shows a very strong growth in Earnings Per Share. The EPS has been growing by 51.64% on average per year.
Looking at the last year, CROX shows a small growth in Revenue. The Revenue has grown by 3.53% in the last year.
CROX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.23% yearly.
EPS 1Y (TTM)9.31%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-2.33%
Revenue 1Y (TTM)3.53%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%3.09%

3.2 Future

CROX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.97% yearly.
CROX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.92% yearly.
EPS Next Y0.75%
EPS Next 2Y3.37%
EPS Next 3Y1.18%
EPS Next 5Y-0.97%
Revenue Next Year2.65%
Revenue Next 2Y3.24%
Revenue Next 3Y2.94%
Revenue Next 5Y3.92%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10

7

4. Valuation

4.1 Price/Earnings Ratio

CROX is valuated reasonably with a Price/Earnings ratio of 8.18.
Based on the Price/Earnings ratio, CROX is valued cheaply inside the industry as 91.84% of the companies are valued more expensively.
CROX is valuated cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 8.12, which indicates a very decent valuation of CROX.
Based on the Price/Forward Earnings ratio, CROX is valued cheaply inside the industry as 91.84% of the companies are valued more expensively.
CROX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.18
Fwd PE 8.12
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 83.67% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CROX is valued a bit cheaper than 79.59% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.79
EV/EBITDA 6.73
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CROX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)10.87
PEG (5Y)0.16
EPS Next 2Y3.37%
EPS Next 3Y1.18%

0

5. Dividend

5.1 Amount

CROX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (2/21/2025, 8:10:57 PM)

After market: 107.58 -0.02 (-0.02%)

107.6

-1.28 (-1.18%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)05-05 2025-05-05/amc
Inst Owners96%
Inst Owner Change3.63%
Ins Owners2.57%
Ins Owner Change-0.44%
Market Cap6.27B
Analysts80.87
Price Target132.62 (23.25%)
Short Float %10.16%
Short Ratio3.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.58%
Min EPS beat(2)9.31%
Max EPS beat(2)13.84%
EPS beat(4)4
Avg EPS beat(4)16.59%
Min EPS beat(4)9.31%
Max EPS beat(4)32.88%
EPS beat(8)8
Avg EPS beat(8)14.13%
EPS beat(12)12
Avg EPS beat(12)15.66%
EPS beat(16)16
Avg EPS beat(16)20.22%
Revenue beat(2)1
Avg Revenue beat(2)0.03%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.83%
Min Revenue beat(4)-1.11%
Max Revenue beat(4)4.37%
Revenue beat(8)4
Avg Revenue beat(8)0.4%
Revenue beat(12)7
Avg Revenue beat(12)0.76%
Revenue beat(16)10
Avg Revenue beat(16)1.73%
PT rev (1m)-4%
PT rev (3m)-18.78%
EPS NQ rev (1m)-0.25%
EPS NQ rev (3m)-0.37%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)-0.15%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.02%
Valuation
Industry RankSector Rank
PE 8.18
Fwd PE 8.12
P/S 1.53
P/FCF 6.79
P/OCF 6.32
P/B 3.42
P/tB N/A
EV/EBITDA 6.73
EPS(TTM)13.15
EY12.22%
EPS(NY)13.25
Fwd EY12.31%
FCF(TTM)15.84
FCFY14.72%
OCF(TTM)17.03
OCFY15.83%
SpS70.39
BVpS31.5
TBVpS-11.2
PEG (NY)10.87
PEG (5Y)0.16
Profitability
Industry RankSector Rank
ROA 19.74%
ROE 51.75%
ROCE 25.69%
ROIC 23.23%
ROICexc 24.31%
ROICexgc 67.44%
OM 25.5%
PM (TTM) 23.16%
GM 58.76%
FCFM 22.5%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
ROICexc(3y)23.62%
ROICexc(5y)33.95%
ROICexgc(3y)69.79%
ROICexgc(5y)62.49%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexcg growth 3Y-0.46%
ROICexcg growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 1.46
Debt/EBITDA 1.21
Cap/Depr 99.29%
Cap/Sales 1.69%
Interest Coverage 10.52
Cash Conversion 88.95%
Profit Quality 97.17%
Current Ratio 1.18
Quick Ratio 0.7
Altman-Z 3.92
F-Score7
WACC10.18%
ROIC/WACC2.28
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.31%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-2.33%
EPS Next Y0.75%
EPS Next 2Y3.37%
EPS Next 3Y1.18%
EPS Next 5Y-0.97%
Revenue 1Y (TTM)3.53%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%3.09%
Revenue Next Year2.65%
Revenue Next 2Y3.24%
Revenue Next 3Y2.94%
Revenue Next 5Y3.92%
EBIT growth 1Y-0.01%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year3.41%
EBIT Next 3Y1.28%
EBIT Next 5Y2.09%
FCF growth 1Y13.29%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y6.67%
OCF growth 3Y20.5%
OCF growth 5Y61.62%